文献速递免疫规划

冻干与悬浮炭疽芽孢疫苗不同温度储存的活力评价

Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures.
PubMed 文献 · Vaccine · 2021-09-15

研究评估冻干和悬浮炭疽疫苗在5°C、20°C和37°C储存6个月内的活芽孢数(CFU/mL)。两种剂型在5°C均维持最低效价6个月;20°C下冻干型维持6个月而悬浮型仅90天;37°C下两者均维持30天。温度偏离推荐范围时疫苗仍可能有效。

要点

  • 5°C储存时两种炭疽疫苗均至少6个月维持最低效价。
  • 20°C储存时冻干疫苗维持6个月,悬浮疫苗维持90天。
  • 37°C储存时两种疫苗均维持最低效价30天。

核心结论

  • 冻干和悬浮炭疽疫苗在高于推荐温度(4-8°C)储存或运输时仍可能保持有效,可继续用于接种计划。

研究设计与样本

  • 评估冻干和悬浮炭疽疫苗在5°C、20°C和37°C储存长达6个月的活芽孢计数(CFU/mL)。

主要发现

  • 两种疫苗在5°C储存6个月均维持不低于推荐最低效价(牛、水牛、马2×10^6可培养芽孢/剂,绵羊、山羊不低于1×10^6)。
  • 20°C储存时冻干疫苗维持最低效价达6个月,悬浮疫苗达90天。
  • 37°C储存时两种疫苗均维持最低效价达30天。
  • 三种温度下两种疫苗效价下降趋势相似,5°C和20°C至90天、37°C至30天的95%CI几乎线性重叠。
  • 5°C和20°C储存90天后、37°C储存30天后效价显著下降(P<0.05),95%CI不重叠。

关键数值与推荐

  • 推荐最低效价:牛、水牛、马为2×10^6可培养芽孢/剂,绵羊、山羊不低于1×10^6。

临床怎么用

  • 若储存或运输发生高于推荐温度范围(4-8°C)的温度偏移,疫苗仍可能有效,可继续用于接种计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anthrax is endemic in Ethiopia with sporadic outbreaks despite the regular vaccination of domestic livestock. This has raised concerns on the effectiveness of the vaccination strategy which may be associated with breaches in the vaccine cold chain maintenance. This study was aimed at demonstrating the tolerance of anthrax vaccine to cold chain breaches through evaluation of viable spore counts expressed as colony forming units per mL (CFU/mL) of freeze-dried and suspension anthrax vaccines stored at 5 °C, 20 °C and 37 °C for up to 6 months. Both vaccine formulations maintained above the recommended minimum required titre (2 × 106 culturable spores per dose for cattle, buffaloes and horses, and not <1 × 106 for sheep and goats) for up to 6 months at 5 °C storage. In storage at 20 °C, the viability of freeze-dried anthrax vaccine maintained the minimum required titre up to 6 months while up to 90 days in case of the suspension formulation. Both types of vaccine formulations maintained the minimum titre per dose for up to 30 days at 37 °C storage. Generally, both vaccine formulations showed similar trends in titre fall in all of the three storage temperatures (5 °C, 20 °C and 37 °C) as observed in the almost linearly overlapping 95% confidence intervals (CI) up to day 90 at 5 °C and 20 °C storages while up to day 30 at 37 °C storage. However, a significant (P < 0.05) drop in titre was observed after day 90 for storages at 5 °C and 20 °C, and after day 30 for 37 °C storage as observed in the non overlapping 95% CI from the average titres of previous time points. This study showed that if temperature excursion occurs above the recommended temperature range (4-8 °C) during storage or transport, the vaccine should remain effective and can still be used in vaccination programs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Abayneh T, Getachew B, Gelaye E, et al. Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures. Vaccine. 2021. PMID: 34538525. doi:10.1016/j.vaccine.2021.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。